These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15603394)

  • 1. [Some aspects of pharmacotherapy of tinnitus. Compound therapy with Xylocaine and directive counseling--long-term results].
    Rogowski M; Sieśkiewicz A; Rózańska-Kudelska M; Walenczak I
    Otolaryngol Pol; 2004; 58(4):807-10. PubMed ID: 15603394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transient evoked otoacoustic emissions (TEOAE) in tinnitus patients treated with xylocaine].
    Sieśkiewicz A; Rogowski M; Gindzieńska E
    Otolaryngol Pol; 2000; 54(1):61-6. PubMed ID: 10822971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic tinnitus in children and adolescents].
    Rosanowski F; Hoppe U; Pröschel U; Eysholdt U
    HNO; 1997 Nov; 45(11):927-32. PubMed ID: 9476106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective evaluation of the effects of intravenous lidocaine on tinnitus.
    Kalcioglu MT; Bayindir T; Erdem T; Ozturan O
    Hear Res; 2005 Jan; 199(1-2):81-8. PubMed ID: 15574302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between tinnitus retraining therapy and a tinnitus control instrument.
    Ito M; Soma K; Ando R
    Auris Nasus Larynx; 2009 Oct; 36(5):536-40. PubMed ID: 19269119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pros and cons of tinnitus retraining therapy.
    Hatanaka A; Ariizumi Y; Kitamura K
    Acta Otolaryngol; 2008 Apr; 128(4):365-8. PubMed ID: 18368566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of intravenous administration of xylocaine for the treatment of tinnitus].
    Yamanaka E; Gyo K; Saiki T; Yanagihara N
    Nihon Jibiinkoka Gakkai Kaiho; 1989 Apr; 92(4):566-73. PubMed ID: 2769474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified version of tinnitus retraining therapy: observing long-term outcome and predictors.
    Mazurek B; Fischer F; Haupt H; Georgiewa P; Reisshauer A; Klapp BF
    Audiol Neurootol; 2006; 11(5):276-86. PubMed ID: 16717441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of intravenous lidocaine for the treatment of subjective tinnitus.
    Otsuka K; Pulec JL; Suzuki M
    Ear Nose Throat J; 2003 Oct; 82(10):781-4. PubMed ID: 14606175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical analysis of directive counselling as a component of tinnitus retraining therapy.
    Wilson PH; Henry JL; Andersson G; Hallam RS; Lindberg P
    Br J Audiol; 1998 Oct; 32(5):273-86. PubMed ID: 9845025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tinnitus retraining therapy: a clinical control study of 117 patients].
    Wang H; Jiang S; Yang W; Han D
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1464-7. PubMed ID: 12509907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinnitus remission by lidocaine demonstrated by auditory-evoked magnetoencephalogram. A preliminary report.
    Shiomi Y; Nagamine T; Fujiki N; Hirano S; Naito Y; Shibasaki H; Honjo I
    Acta Otolaryngol; 1997 Jan; 117(1):31-4. PubMed ID: 9039477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the tinnitus retraining therapy trial.
    Formby C; Scherer R;
    Noise Health; 2013; 15(63):134-42. PubMed ID: 23571304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25 years of tinnitus retraining therapy.
    Jastreboff PJ
    HNO; 2015 Apr; 63(4):307-11. PubMed ID: 25862626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cochlear tinnitus with transtympanic infusion of 4% lidocaine into the tympanic cavity.
    Sakata H; Kojima Y; Koyama S; Furuya N; Sakata E
    Int Tinnitus J; 2001; 7(1):46-50. PubMed ID: 14964956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of patients for treatment with tinnitus retraining therapy.
    Henry JA; Jastreboff MM; Jastreboff PJ; Schechter MA; Fausti SA
    J Am Acad Audiol; 2002; 13(10):523-44. PubMed ID: 12503922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical trial of tinnitus retraining therapy.
    Herraiz C; Hernandez FJ; Plaza G; de los Santos G
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):774-9. PubMed ID: 16274808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidocaine: neurobiological targets and effects on the auditory system.
    Trellakis S; Lautermann J; Lehnerdt G
    Prog Brain Res; 2007; 166():303-22. PubMed ID: 17956794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical treatment of tinnitus.
    Shea JJ; Emmett JR; Orchik DJ; Mays K; Webb W
    Ann Otol Rhinol Laryngol; 1981; 90(6 Pt 1):601-9. PubMed ID: 7032398
    [No Abstract]   [Full Text] [Related]  

  • 20. Tinnitus retraining therapy: prognosis factors.
    Herraiz C; Hernandez FJ; Toledano A; Aparicio JM
    Am J Otolaryngol; 2007; 28(4):225-9. PubMed ID: 17606035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.